MECHANICS AND FUNCTIONS OF THE N-END RULE PATHWAY

N 端规则路径的机制和功能

基本信息

项目摘要

Ubiquitin is a 76-residue protein that exists in cells either free or conjugated to many other proteins. Selective degradation of proteins by the ubiquitin/proteasome-dependent pathways plays a role in a multitude of biological processes, including cell growth and differentiation, signal transduction and responses to stress. One ubiquitin/proteasome-dependent proteolytic system is the N-end rule pathway, identified by the laboratory in 1986. The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue. The N-end rule pathway is present in all organisms examined, from mammals to bacteria. Studies supported by the present grant ("Mechanics and Functions of the N-end Rule Pathway", DK39520), currently in its 11th year, have yielded significant insights into the N-end rule's functions and mechanisms, as described in the Progress Report. The objective of the research described in this renewal application is to advance the understanding of the N-end rule pathway and related aspects of the ubiquitin system. Specific aims are: 1) Regulation of peptide import by the N-end rule pathway: biochemical and genetic studies; 2) A fusion-based screen for physiological substrates of the N-end rule pathway in S. cerevisiae; 3) Isolation and analysis of regulators of the N-end rule pathway; 4) Screens for mutants whose viability requires the presence of the N-end r; 5) The use of suppression subtractive hybridization to identify new functions of the N-end rule pathway; 6) Analysis of a mitochondrial function of the Ntalp N-terminal amidase in S. cerevisiae; 7) A biochemico-genetic approach to identification of physiological N-end rule substrates; 8) A "double-headed" inhibitor of the N-end rule pathway; 9) The "two-ubiquitin" technique and its application to the problem of cotranslational proteolysis; and 10) Biochemical and genetic dissection of the UBRI-encoded Nrecognin and Ubr2p, a recently identified homolog of Ubrlp in S. cerevisiae.
泛素是存在于细胞中的76个残基的蛋白质,其以游离形式或与许多其他蛋白质缀合。通过泛素/蛋白酶体依赖性途径选择性降解蛋白质在许多生物过程中发挥作用,包括细胞生长和分化、信号转导和对应激的反应。一种泛素/蛋白酶体依赖的蛋白水解系统是N-末端规则途径,由实验室在1986年鉴定。N-末端规则将蛋白质的体内半衰期与其N-末端残基的身份联系起来。N端规则途径存在于从哺乳动物到细菌的所有生物体中。目前资助的研究(“N端规则途径的机制和功能”,DK 39520),目前已进入第11个年头,对N端规则的功能和机制产生了重要的见解,如进度报告所述。本更新申请中描述的研究目的是促进对N端规则途径和遍在蛋白系统相关方面的理解。具体目标是:1)N-末端规则途径对肽输入的调控:生化和遗传学研究; 2)基于融合的S.酿酒酵母; 3)分离和分析N-末端规则途径的调节子; 4)筛选其生存力需要N-末端r存在的突变体; 5)使用抑制消减杂交来鉴定N-末端规则途径的新功能; 6)分析S.酿酒酵母; 7)鉴定生理性N-末端规则底物的生物化学-遗传学方法; 8)N-末端规则途径的“双头”抑制剂; 9)“双泛素”技术及其在共翻译蛋白质水解问题中的应用;和10)UBRI编码的Nrecognin和Ubr 2 p的生物化学和遗传学解剖,Ubr 2 p是最近在S.啤酒。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDER J VARSHAVSKY其他文献

ALEXANDER J VARSHAVSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDER J VARSHAVSKY', 18)}}的其他基金

Ubiquitin Ligases, Mechanisms and Functions of the N-End Rule Pathway
N 端规则通路的泛素连接、机制和功能
  • 批准号:
    7996378
  • 财政年份:
    2009
  • 资助金额:
    $ 63.17万
  • 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
  • 批准号:
    7513269
  • 财政年份:
    2008
  • 资助金额:
    $ 63.17万
  • 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
  • 批准号:
    8118431
  • 财政年份:
    2008
  • 资助金额:
    $ 63.17万
  • 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
  • 批准号:
    7661504
  • 财政年份:
    2008
  • 资助金额:
    $ 63.17万
  • 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
  • 批准号:
    7871450
  • 财政年份:
    2008
  • 资助金额:
    $ 63.17万
  • 项目类别:
MULTITARGET DRUGS: VERIFICATION-OF-PRINCIPLE STUDIES
多靶点药物:原理验证研究
  • 批准号:
    6033211
  • 财政年份:
    2000
  • 资助金额:
    $ 63.17万
  • 项目类别:
MULTITARGET DRUGS: VERIFICATION-OF-PRINCIPLE STUDIES
多靶点药物:原理验证研究
  • 批准号:
    6342202
  • 财政年份:
    2000
  • 资助金额:
    $ 63.17万
  • 项目类别:
The GID Ubiquitin Ligase and the Pro/N-End Rule Pathway in Yeast and Mammals
酵母和哺乳动物中的 GID 泛素连接酶和 Pro/N 端规则通路
  • 批准号:
    10202561
  • 财政年份:
    1995
  • 资助金额:
    $ 63.17万
  • 项目类别:
MECHANICS AND FUNCTIONS OF THE N-END RULE PATHWAY
N 端规则路径的机制和功能
  • 批准号:
    7007642
  • 财政年份:
    1995
  • 资助金额:
    $ 63.17万
  • 项目类别:
The Mammalian Arg/N-End Rule Pathway: Substrates, Functions, and Mechanisms
哺乳动物 Arg/N 端规则途径:底物、功能和机制
  • 批准号:
    8601698
  • 财政年份:
    1995
  • 资助金额:
    $ 63.17万
  • 项目类别:

相似国自然基金

Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
  • 批准号:
    81971557
  • 批准年份:
    2019
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
  • 批准号:
    51678163
  • 批准年份:
    2016
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目

相似海外基金

Did light dictate ancient diversification of phylogeny and cell structure in the domain bacteria?
光是否决定了细菌领域的古代系统发育和细胞结构的多样化?
  • 批准号:
    24H00582
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Cell Wall Formation in Rod Shaped Bacteria
杆状细菌细胞壁的形成
  • 批准号:
    BB/Y003187/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Research Grant
DNA replication dynamics in living bacteria
活细菌中的 DNA 复制动态
  • 批准号:
    23K25843
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Conference: Symposium on the Immune System of Bacteria
会议:细菌免疫系统研讨会
  • 批准号:
    2349218
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Standard Grant
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
  • 批准号:
    EP/Y029542/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Fellowship
Assembly of the matrix that supports bacteria living in biofilms
支持生活在生物膜中的细菌的基质的组装
  • 批准号:
    2468773
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Studentship
Manipulating two-component systems to activate cryptic antibiotic pathways in filamentous actinomycete bacteria
操纵双组分系统激活丝状放线菌中的神秘抗生素途径
  • 批准号:
    BB/Y005724/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Research Grant
CAREER: Interfacial behavior of motile bacteria at structured liquid crystal interfaces
职业:运动细菌在结构化液晶界面的界面行为
  • 批准号:
    2338880
  • 财政年份:
    2024
  • 资助金额:
    $ 63.17万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了